MTF Biologics – Dermal Allograft Innovation Grants (2026)
The Dermal Allograft Innovation Grants from MTF Biologics support translational research advancing next-generation technologies in allograft dermis and skin. This new 2026 funding opportunity focuses on expanding the clinical utility of dermal matrices and skin allografts beyond traditional sheet-based formats to enable new applications, improve handling and storage, and enhance patient outcomes.
Allograft dermal matrices (ADMs) and skin allografts are widely used in reconstructive and regenerative procedures, including breast surgery, wound healing, and abdominal wall reconstruction. MTF Biologics is seeking innovative research that introduces transformative product forms, processing methods, and delivery technologies for dermal and skin allografts.
Organization
MTF Biologics
Support Type
Translational research grants
Geographic Focus
United States (academic and research institutions)
About the Funder
MTF Biologics is a nonprofit organization dedicated to advancing tissue-based solutions that improve patient care. Through its research grant programs, MTF Biologics invests in innovative science that accelerates the development of clinically meaningful allograft technologies across surgical and regenerative medicine applications.
Program Objectives
The Dermal Allograft Innovation Grants aim to support research that:
- Drives technological breakthroughs in dermal and skin allografts beyond sheet-based formats
- Develops new tissue product forms such as flowable, particulate, injectable, or modular ADM
- Explores integration with advanced platforms, including 3D bioprinting and tissue engineering
- Innovates processing and preservation technologies, including room-temperature storage solutions
- Advances ADM applications within existing clinical indications through novel product designs
Examples of Eligible Research Areas
- Novel dermal or skin allograft forms (flowable, injectable, hybrid, or modular constructs)
- Advanced dermis or skin compositions, including 3D-printing-compatible biomaterials and viable allograft tissues
- Processing technologies that improve shelf life, sterility, preservation, transportability, or usability
- Translational studies demonstrating clinical feasibility, improved performance, or expanded applications
Other research topics aligned with program objectives will also be considered.
Exclusions
The program will not support:
- Projects limited to incremental improvements of existing ADM sheet products without significant innovation
- Projects where the enabling technology is not allograft-based
Funding & Eligibility
- Funding Amount: Up to $100,000 for a 12-month project
- Up to two additional 12-month funding cycles may be awarded based on progress and impact
- Eligible applicants include investigators with expertise in tissue engineering, regenerative medicine, biomaterials science, plastic and reconstructive surgery, or related fields
- Applicants must hold an appointment at an academic institution, teaching hospital, or research organization
Application Timeline
- Letters of Intent Due: March 23, 2026
- LOI Review & Invitation for Full Proposal: By end of April 2026
- Full Proposal Due (by invitation): June 15, 2026
- Awards Announced: By end of October 2026
Application Process
Applicants must first submit a Letter of Intent (LOI). Only applicants with positively reviewed LOIs will be invited to submit a full proposal. Full submission requirements and evaluation criteria are detailed in the official RFP.
Apply / Learn More
➡️ 2026 Dermal Allograft Innovation Grant RFP (PDF):
https://www.mtfbiologics.org/docs/default-source/grant-applications/2026/mtf-biologics-2026-dermal-grant-rfp.pdf?sfvrsn=5dc41a42_3
Why This Opportunity Is a Good Fit
This grant is a strong fit for researchers developing transformative dermal and skin allograft technologies with clear translational potential. It is particularly well suited for teams working on innovative product forms, preservation methods, and tissue-engineered solutions that address unmet clinical needs.
